Free Research Report on Oshkosh Corp., OCZ Technology Group Inc., LipoScience, Inc., Netflix, Inc. and Sarepta Therapeutics, Inc.

Mon Jan 28, 2013 8:01am EST

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130128:nPn1282554


NEW YORK,  January 28, 2013  /PRNewswire/ --

Today, Traders Insight announced new research reports highlighting Oshkosh Corp.
(NYSE: OSK), OCZ Technology Group Inc. (Nasdaq: OCZ), LipoScience, Inc. (Nasdaq:
LPDX), Netflix, Inc. (Nasdaq: NFLX) and Sarepta Therapeutics, Inc. (Nasdaq:
SRPT). Today's readers may access these reports free of charge - including full
price targets, industry analysis and analyst ratings - via the links below.


Oshkosh Corp. Research Report

Oshkosh Corporation (Oshkosh) is a designer, manufacturer and marketer of a
broad range of specialty vehicles and vehicle bodies. The Company partners with
customers to deliver superior solutions that safely and efficiently move people
and materials at work, around the globe, and around the clock. The Full Research
Report on Oshkosh Corp. - including full detailed breakdown, analyst ratings and
price targets - is available to download free of charge at:
[http://www.TradersInsight.net/r/2013-01-28/d42f_OSK]

OCZ Technology Group Inc. Research Report

OCZ Technology Group, Inc. (OCZ) designs, manufactures, and distributes
solid-state drives (SSDs) and computer components. OCZ designs and manufactures
SSDs in a variety of form factors and interfaces including Serial advanced
technology attachment (SATA), serial-attached small computer system interface
(SAS), peripheral component interconnect express (PCIe), as well as the
development of flash management software, caching and virtualization software.
The Full Research Report on OCZ Technology Group Inc. - including full detailed
breakdown, analyst ratings and price targets - is available to download free of
charge at: [http://www.TradersInsight.net/r/2013-01-28/b071_OCZ]

LipoScience, Inc. Research Report

The Full Research Report on LipoScience, Inc. - including full detailed
breakdown, analyst ratings and price targets - is available to download free of
charge at: [http://www.TradersInsight.net/r/2013-01-28/2ebc_LPDX]

Netflix, Inc. Research Report

Netflix, Inc. (Netflix) is an Internet subscription service streaming television
shows and movies. The Company's subscribers can watch unlimited television shows
and movies streamed over the Internet to their televisions, computers and mobile
devices, and in  the United States, subscribers can also receive digital
versatile discs (DVDs) delivered to their homes. The Company operates in three
segments: Domestic streaming, International streaming and Domestic DVD. The Full
Research Report on Netflix, Inc. - including full detailed breakdown, analyst
ratings and price targets - is available to download free of charge at:
[http://www.TradersInsight.net/r/2013-01-28/daa1_NFLX]

Sarepta Therapeutics, Inc. Research Report

Sarepta Therapeutics Inc., formerly AVI BioPharma, Inc., biopharmaceutical
company focused on the discovery and development of ribonucleic acid (RNA)-based
therapeutics for the treatment of rare and infectious diseases. Its product
candidates include Eteplirsen, AVI-6002, AVI-6003, and AVI-7100. The Full
Research Report on Sarepta Therapeutics, Inc. - including full detailed
breakdown, analyst ratings and price targets - is available to download free of
charge at: [http://www.TradersInsight.net/r/2013-01-28/7a2c_SRPT]

About Traders Insight

Our model of enabling open collaboration between members is breaking new ground
into the investment community. By tapping into the resources of the community,
we are crowd-sourcing our reach. As a result -- we have been able to identify
some of the greatest moving companies on the market today. The evidence is in
the results, join today and experience what you've been missing.




Press Contact:

Cora S. Patton
press@TradersInsight.net

+1-203-297-6092


SOURCE  Traders Insight

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.